Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.
about
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative StressExploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular DiseaseOrganic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.miRNA-130b is required for the ERK/FOXM1 pathway activation-mediated protective effects of isosorbide dinitrate against mesenchymal stem cell senescence induced by high glucose.Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure.Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.Oxidative stress and endothelial dysfunction: therapeutic implications.Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives.Vasodilator Therapy: Nitrates and Nicorandil.Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazol.Heme oxygenase-1 induction and organic nitrate therapy: beneficial effects on endothelial dysfunction, nitrate tolerance, and vascular oxidative stressRegulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro.Endothelial progenitor cells=EPC=elemental pernicious complexityChronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression.Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates.Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.
P2860
Q26799354-F51C1988-966F-4CDC-B9AA-E8360CCD4FB5Q26801173-1E2B6722-66CA-48C5-A441-91CD127E4317Q34460615-9C3FC736-58AF-4F71-B968-55254ED9FC3FQ34599029-06FE669B-0521-4F18-B934-2398B7543FE2Q35227188-D8FF15BB-938E-473C-9FF9-A38B47964D44Q35619474-1A8E1691-5594-4594-9D44-A9816C504742Q37699822-19A0ACB6-E3F1-468E-8D88-7CA8995D00C4Q37834017-1124380A-9895-4336-9685-305B91354A52Q37963774-4C5FDE1B-3D0C-4C98-B356-A43E03573BABQ38867313-DBD2CB1A-1693-44B2-A075-BBFEF11333D1Q39541710-6C025BC8-B86F-4A0F-B342-36BE82F826D3Q41842570-9F49461C-DDCB-4B5F-A265-0EBEA8265E07Q41932170-4B97DAB6-722C-4F50-923C-111BDFD91385Q42798882-E67CF5A5-5674-4CE5-B694-4ADAFEA77C09Q44016035-AEDDA41C-3601-445E-8219-F1FE958D06F2Q44190177-D6FA6DF3-9F88-479C-90BB-090B759C3BE5Q45915404-34B459D4-A74D-49B6-A458-734BD85D3ED9
P2860
Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@en
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@nl
type
label
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@en
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@nl
prefLabel
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@en
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@nl
P2860
P356
P1476
Non-hemodynamic effects of org ...... pentaerithrityl tetranitrate.
@en
P2093
Andreas Daiber
Tommaso Gori
P2860
P2888
P356
10.1007/BF03256591
P577
2009-01-01T00:00:00Z